Left and right coronary circulation in left ventricular hypertrophy - Effects of angiotensin converting enzyme inhibition

Circulation Journal

Volumn 66, Issue 12, 2002, Pages 1168-1172

  Shimada, Yasuyuki ^a   Avkiran, Metin ^b  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Coronary reserve; Left ventricular hypertrophy; Ramipril

Indexed keywords

ADENOSINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPEPTIDYL PEPTIDASE; RAMIPRIL; DIPEPTIDYL CARBOXYPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE THERAPY; AORTA CONSTRICTION; ARTICLE; BLOOD PRESSURE MEASUREMENT; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY VASCULAR RESISTANCE; DOSE RESPONSE; ENZYME ACTIVITY; ENZYME INHIBITION; HEART LEFT VENTRICLE HYPERTROPHY; MALE; NONHUMAN; RAT; ANIMAL; BLOOD; BLOOD PRESSURE; DRUG EFFECT; HEART MUSCLE; ORGAN SIZE; PATHOLOGY; PATHOPHYSIOLOGY; VASCULAR RESISTANCE; WISTAR RAT;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CORONARY CIRCULATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERTROPHY, LEFT VENTRICULAR; MALE; MYOCARDIUM; ORGAN SIZE; PEPTIDYL-DIPEPTIDASE A; RAMIPRIL; RATS; RATS, WISTAR; VASCULAR RESISTANCE;

EID: 0036894193     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.66.1168     Document Type: Article

References (34)

1. Levy D, Anderson KM, Savage DD, Balkus SA, Kannel WB, Castelli WP. Risk of ventricular arrhythmias in left ventricular hypertrophy: The Framingham heart study. Am J Cardiol 1987; 60: 560-565.
2. Aronow WS, Epstein S, Koenisberg M, Schwartz KS. Usefulness of echocardiographic left ventricular hypertrophy, ventricular tachycardia and complex ventricular arrhythmias in predicting ventricular fibrillation or sudden cardiac death in elderly patients. Am J Cardiol 1988; 62: 1124-1125.
3. Dunn FG, Pringle SD. Sudden cardiac death, ventricular arrhythmias and hypertensive left ventricular hypertrophy [editorial]. J Hypertens 1993; 11: 1003-1010.
4. Burke AP, Farb A, Sessums L, Virmani R. Causes of sudden cardiac death in patients with replacement valves: An autopsy study. J Heart Valve Dis 1994; 3: 10-16.
5. Thakur RK. Ventricular arrhythmias in the elderly. Can J Cardiol 1994; 10: 119-124.
6. Shimada Y, Gunasegaram S, Yokoyama H, Avkiran M. Inhibition of angiotensin converting enzyme reduces susceptibility of hypertrophied rat myocardium to ventricular fibrillation. Jpn Circ J 2002; 66: 1045-1053.
7. Shimada Y, Yaku H, Kawata M, Oka K, Syuntoh K, Takahashi A, et al. Impact of myocardial ACE activity on coronary vascular resistance and post-operative BNP (abstract). Jpn Circ J 2000; 65(Suppl I-A): 133.
8. Yamamoto H, Avkiran M. Left ventricular pressure overload during postnatal development: Effects on coronary vasodilator reserve and tolerance to hypothermic global ischemia J Thorac Cardiovasc Surg 1993; 105: 120-131.
9. Ito N, Isoyama S, Kuroha M, Takishima T. Duration of pressure overload alters regression of coronary circulation abnormalities. Am J Physiol 1990; 258: 1753-1760.
10. Isoyama S, Ito N, Kuroha M, TakishimaT. Complete reversibility of physiological coronary vascular abnormalities in hypertrophied hearts produced by pressure overload in the rat. J Clin Invest 1989; 84: 288-294.
11. Brilla CG, Janicki JS, Weber KT. Impaired diastolic function and coronary reserve in genetic hypertension: Role of interstitial fibrosis and medial thickening of intramyocardial coronary arteries. Circ Res 1991; 69: 107-115.
12. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991: 83: 1771-1179.
13. Ito N, Nitta Y, Ohtani H, Ooshima A, Isoyami S. Remodeling of microvessels by coronary hypertension or cardiac hypertrophy in rats. J Mol Cell Cardiol 1994; 26: 49-59.
14. El Amrani FC, Cheaw SL, Chevalier B, Paolaggi F, Jouquey S, Hamon G, et al. Regression of left ventricular hypertrophy by converting enzyme inhibition in 12-15 month old spontaneously hypertensive rats: Effects on coronary resistance and ventricular compliance in normoxia and anoxia. J Cardiovasc Pharmacol 1994; 23: 155-165
15. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, et al. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat. Circulation 1994; 89: 2273-2282.
16. Levy LB, Avkiran M, Ferrari R, Hearse DJ. Impaired skeletal muscle fatigue resistance in rats with pressure overloaded-induced left ventricular hypertrophy. J Mol Cell Cardiol 1996; 28: 183-195.
17. Avkiran M, Curtis MJ. Independent dual perfusion of left and right coronary arteries in isolated rat hearts. Am J Physiol 1991; 261: H2082-H2090.
18. Maxwell MP, Hearse DJ, Yellon DM. Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rat of evolution and extent of myocardial infarction. Cardiovasc Res 1987: 21: 737-746.
19. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980; 47: 1-9.
20. Wangler RD, Peters KG, Marcus ML, Tomanek RJ. Effects of duration and severity of arterial hypertension and cardiac hypertrophy on coronary vasodilator reserve. Circ Res 1982; 51: 10-8.
21. Bourdarias JP. Coronary reserve: Concept and physiological variations. Eur Heart J 1995; 16(Suppl 1): 2-6.
22. 31P magnetic resonance spectroscopy of pressure overload hypertrophy in rats: Effect of reduced perfusion pressure. Cardiovasc Res 1990; 24: 57-64.
23. Unger T, Mattfeldt T, Bock P, Lamberty V, Mall G, Linz W, et al. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension 1992; 20: 478-482.
24. Tomanek RJ. Response of the coronary vasculature to myocardial hypertrophy. J Am Coll Cardiol 1990; 15: 528-533.
25. Linz W, Schaper J, Wiemer G, Albus U, Scholkens BA. Ramipril prevents left ventricular hypertrophy with myocardial fibrosis without blood pressure reduction: A one year study in rats. Br J Pharmacol 1992; 107: 970-975.
26. Linz W, Scholkens BA. Role of bradykinin in the cardiac effects of angiotensin converting enzyme inhibitors. J Cardiovasc Pharmacol 1992; 20(Suppl 9): S83-S90.
27. Nagasawa K, Zimmermann R, Munkel B, Linz W, Scholkens BA, Schaper J. Extracellular matrix deposition in hypertensive hearts: Antifibrotic effects of ramipril. Eur Heart J 1995; 16(Suppl C): 33-37.
28. Komuro I. Molecular mechanism of cardiac hypertrophy and development. Jpn Circ J 2001; 65: 353-358.
29. Pringle SD, Dunn FG, Macfarlane PW, McKillop JH, Lorimer AR, Cobbe SM. Significance of ventricular arrhythmias in systemic hypertension with left ventricular hypertrophy. Am J Cardiol 1992; 69: 913-917.
30. Richard AM, Nicholls MG, Crozier IG. Role of ACE inhibitors in hypertension with left ventricular hypertrophy. Br Heart J 1994: 72: S24-S32.
31. Linz W, Wiemer G, Scholkens BA. Contribution of bradykinin to the cardiovascular effects of ramipril. J Cardiovasc Pharmacol 1993; 22(Suppl 9): S1-S8.
32. Michel JB. Relationship between decrease in afterload and beneficial effects of ACE inhibitors in experimental cardiac hypertrophy and congestive heart failure. Eur Heart J 1990; 11(Suppl D): 17-26.
33. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991; 325: 293-302.
34. The SLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992; 327: 685-691.